Author:
Faatz Henrik,Farecki Marie-Louise,Rothaus Kai,Gunnemann Frederic,Gutfleisch Matthias,Lommatzsch Albrecht,Pauleikhoff Daniel
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Bressler NM. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol Chic Ill 1960. 2001;119:198–207.
2. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–44.
https://doi.org/10.1056/NEJMoa062655.
3. Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina Phila Pa. 2010;30:1333–49.
https://doi.org/10.1097/IAE.0b013e3181e7976b.
4. Matthé E, Sandner D. Early treatment of exudative age-related macular degeneration with ranibizumab (Lucentis®): the key to success. Ophthalmol Z Dtsch Ophthalmol Ges. 2011;108:237–43.
https://doi.org/10.1007/s00347-010-2282-9.
5. Kuehlewein L, Bansal M, Lenis TL, Iafe NA, Sadda SR, Bonini Filho MA, et al. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol. 2015;160:739–.e2.
https://doi.org/10.1016/j.ajo.2015.06.030
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献